Solr Search

patients everywhere., We are at this rare moment in history when technology, policy, and urgency to change converge to create a perfect storm of innovation. , At this time in history when the country is experiencing workforce shortages, supply chain breakdowns, and pressure on the bottom line, embracing change is hard.

g, renowned molecular biologist and Nobel Laureate, Innovation will continue to provide new and more effective ways to fight our evolving enemy. , One example is Orna Therapeutics, a company developing the next generation of RNA technology: circular RNA. Circular RNA technology was originally invented at MIT and has immense potential to address key limitations of mRNA.

yone has access to the nutritious food they need to live healthier lives. , Practitioners, researchers, and policymakers have rightly moved beyond focusing solely on food security to also focus on nutrition security—that is, access to healthy food.

the modification or manipulation of gene expression, are becoming a clinical reality, holding incredible promise for millions of patients., Stakeholders must be proactive to effectively incorporate patient goals and perspectives throughout the gene therapy development process. , The Cystic Fibrosis Foundation is dedicated to ensuring that people with cystic fibrosis (CF) have the opportunity to lead long, fulfilling lives, with the ultimate goal of curing CF.

r, anxiety, and many questions. What will the treatment be like? Can I continue working? How will my family cope? Will I survive?, It's our moral obligation to continue pushing for policies that make cancer care more affordable and more accessible. , While major cancer centers deliver cutting-edge therapies and care, many patients do not live near these hospitals.

al pharmaceutical supply chain, they have also revealed blind spots, such as growing health inequities, that threaten our ability to advance broader publ, Responding to supply chain challenges requires adaptation and coordination. , Addressing Health Equity Challenges and Opportunities COVID-19 has reinforced that large-scale public health challenges can further dr

of aging, turn this dream into a nightmare., Paradigm shifts in business and policy sectors will ensure that effective treatments ultimately reach patients who need a cure today. , What’s the ‘Germ Theory of Disease’ Got to Do With It? This theory captured the minds of scientists and the public, with its ability to explain and treat many of the maladies encountered by humans in the 19th century.

l-being has fueled a lifetime calling to health care. We, as physicians, have an unwaning commitment to guiding our patients through a health journey., We have an immense opportunity to influence life expectancy trends when treating those living with chronic illnesses. , Where are these journeys being cut short, and how can we support health-care professionals and health systems to course correct for the benefit of the health, well-being, and lifespan of more patients?

., We are on the way to changing the paradigm of getting sick and quickly accumulating diseases later in life. , A growing number of aging’s biological changes, or hallmarks, can be targeted by drugs and other technologies to improve both life span and health span (the time we remain in good condition).

rmerly little known, post-viral illnesses., While this pandemic has created a tsunami of illness that has ravaged mankind, it has simultaneously created hope for millions. , Long COVID and ME/CFS Post-viral and post-infectious chronic illnesses aren’t new.

e pleased to announce the annual rec

e individuals selected to receive the 2022 Metabolic Mind Award for their exceptional contributions to the advancement of understanding Ketogenic